RIPK1-IN-4 - HY-18901
Nur noch %1 verfügbar
Catalog #
HY-18901
Ab
300,00 €
RIPK1-IN-4 (compound 8) is a potent and selective type II kinase inhibitor of receptor interacting protein 1 (RIP1) kinase and binds to a DLG-out inactive form of RIP1 with an IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-18901/RIPK1-IN-4-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-immunoregulation |
| CAS | 1481641-08-0 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 401.46 |
| Solubility | DMSO : 250 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | RIP kinase |
| Application: | COVID-19-immunoregulation |
|---|